Showing 8,781 - 8,800 results of 32,320 for search '(( 50 ((nn decrease) OR (((we decrease) OR (a decrease)))) ) OR ( e point decrease ))', query time: 0.99s Refine Results
  1. 8781

    Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study by David N. Franz (822882)

    Published 2016
    “…Everolimus was initiated at a dose (4.5 mg/m<sup>2</sup>/day) titrated to a target blood trough of 5–15 ng/mL. …”
  2. 8782

    Synthesis, Crystal Structure Analysis, and Photoluminescence of Ti<sup>4+</sup>-Doped Mg<sub>5</sub>SnB<sub>2</sub>O<sub>10</sub> by Tetsuya Kawano (2253721)

    Published 2010
    “…A broad blue emission with a peak wavelength of ∼430 nm was observed from the solid solutions under 265-nm ultraviolet excitation. …”
  3. 8783

    Intensity of 7-day running training in rats. by Chengcheng Li (2591632)

    Published 2025
    “…</p><p> Methods </p><p>In the in vitro study, 6-8-week-old male rats were subjected to treadmill exercise at an ambient temperature of (39.5 ± 0.5)°C and relative humidity of 50%-60%, at a speed of 15 meters per minute until their core body temperature (Tc) reached 43.0°C to establish a heatstroke animal model. …”
  4. 8784
  5. 8785

    Probing the Sensitivity of the Orbitrap Lumos Mass Spectrometer Using a Standard Reference Protein in a Complex Background by Michaella J. Levy (1564081)

    Published 2018
    “…The Orbitrap Fusion Lumos mass spectrometer has recently been shown to have better fragmentation and detection than its predecessors. Here, we determined the sensitivity of the Lumos using the NIST monoclonal antibody reference material at various concentrations to detect its peptides in a background of <i>S. cerevisiae</i> whole cell lysate, which was kept at a constant concentration. …”
  6. 8786

    Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments by Stefania Ferro (76724)

    Published 2018
    “…In particular, we designed and synthesized a series of 1-(4-fluorobenzyl)­piperazine and 1-(4-fluorobenzyl)­piperidine derivatives showing inhibitory activities on TyM at micromolar ranges and more potency than that of the reference compound, kojic acid. …”
  7. 8787

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  8. 8788

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  9. 8789

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  10. 8790

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  11. 8791

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  12. 8792

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  13. 8793

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  14. 8794

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  15. 8795

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  16. 8796

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  17. 8797

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  18. 8798

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  19. 8799

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  20. 8800

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”